rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8998
|
pubmed:dateCreated |
1996-4-23
|
pubmed:abstractText |
A randomised trial comparing filgrastim-mobilised peripheral blood progenitor cell (PBPC) transplants with autologous bone marrow transplantation (ABMT) for haematopoietic stem cell support has not been done. We compared the effects of filgrastim-mobilised PBPC or autologous bone marrow reinfused to lymphoma patients after high-dose chemotherapy in a prospective randomised multicentre trial.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0140-6736
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
347
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
353-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8598700-Adult,
pubmed-meshheading:8598700-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8598700-Bone Marrow Transplantation,
pubmed-meshheading:8598700-Carmustine,
pubmed-meshheading:8598700-Combined Modality Therapy,
pubmed-meshheading:8598700-Cytarabine,
pubmed-meshheading:8598700-Female,
pubmed-meshheading:8598700-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:8598700-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:8598700-Hodgkin Disease,
pubmed-meshheading:8598700-Humans,
pubmed-meshheading:8598700-Leukocytes, Mononuclear,
pubmed-meshheading:8598700-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8598700-Male,
pubmed-meshheading:8598700-Melphalan,
pubmed-meshheading:8598700-Platelet Transfusion,
pubmed-meshheading:8598700-Podophyllotoxin,
pubmed-meshheading:8598700-Prospective Studies,
pubmed-meshheading:8598700-Recombinant Proteins,
pubmed-meshheading:8598700-Survival Analysis,
pubmed-meshheading:8598700-Time Factors,
pubmed-meshheading:8598700-Transplantation, Autologous
|
pubmed:year |
1996
|
pubmed:articleTitle |
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
|
pubmed:affiliation |
Department of Internal Medicine II, Christian-Albrechts-Universität, Kiel, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|